Anu's Laboratories IPO
Anu's Laboratories IPO — date, price band, lot size & details 2008
Anu's Laboratories listed on 4 Jun 2008 at ₹260, 23.8% above the ₹210 issue price.
Anu's Laboratories is a Hyderabad based maker of drug intermediates, including products such as CIS plus Hydroxy Lactum and Sodium Methoxide. Its total income was Rs 121.30 crore in FY2007.
Researched & reviewed by
Abhishek Vohera,
Founder, IPO Guru
Last updated
Figures sourced from the RHP, BSE & NSE
Timetable
Key dates from opening to listing. Today is 12 November.
- Open 12 May 2008
- Close 15 May 2008
- Allotment 26 May 2008
- Refund/credit TBA
- Listing 04 Jun 2008
Issue summary
The terms of the offer, as filed.
| IPO Dates | 12 to 15 May, 2008 |
|---|---|
| Price Band | ₹200 – ₹210 |
| Face Value | ₹10 |
| Lot Size | 30 Shares |
| Issue Size | ₹80.22 Cr |
| Sale Type | Fresh capital only |
| Listing On | BSE |
| Registrar | KFin Technologies Limited |
| Min Investment | ₹ 6,300 |
Share of the offer set aside for each investor category, as stated in the offer document.
What will it cost me?
Bidding is in multiples of 30 shares at the ₹210 cut-off. Drag to size your application.
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (min) | 1 | 30 | ₹6,300 |
| Retail (max) | 31 | 930 | ₹1,95,300 |
| S-HNI (min) | 32 | 960 | ₹2,01,600 |
| S-HNI (max) | 158 | 4,740 | ₹9,95,400 |
| B-HNI (min) | 159 | 4,770 | ₹10,01,700 |
Strengths & risks
Drawn from the offer document — the case for and against, side by side.
Strengths · 4
- 01Total income rose from Rs 67.22 crore in FY2005 to Rs 121.30 crore in FY2007, and was Rs 113.82 crore in nine months to December 2007.
- 02Profit before extraordinary items rose from Rs 2.09 crore in FY2005 to Rs 13.59 crore in FY2007, and was Rs 13.12 crore in nine months to December 2007.
- 03Net worth rose from Rs 7.44 crore in FY2005 to Rs 44.96 crore in December 2007.
- 04Rs 55.09 crore of the issue was for a new plant for intermediates and APIs.
Risks · 5
- 01Much of its growth came from 2 products, CIS plus Hydroxy Lactum and Sodium Methoxide.
- 02It relied on Nitya Laboratories' facilities for job work, paying advances of Rs 4.51 crore in FY2007.
- 03Drug intermediate prices are competitive; Rs 16.67 crore of the issue was for working capital.
- 04Rs 8.34 crore was for a contract research pilot plant, a new business.
- 05Promoter holding fell from 74.79% before the issue to 51.13% after it.
Three years of numbers
All figures in ₹ crore, as reported in the Anu's Laboratories offer document.
| Metric | 31 Dec 2007 | 31 Mar 2007 | 31 Mar 2006 | 31 Mar 2005 |
|---|---|---|---|---|
| Total Income | 113.82 | 121.30 | 95.34 | 67.22 |
| Profit After Tax | 13.12 | 13.59 | 5.71 | 2.09 |
| NET Worth | 44.96 | 31.51 | 12.88 | 7.44 |
See how this IPO compares — view listing performance of all mainboard IPOs.
Where the money goes
₹92.22 Cr of the issue is earmarked to named objects.
About the company
It makes drug intermediates for pharmaceutical companies.
Its sales jumped after it introduced two products in 2004-05, CIS plus Hydroxy Lactum and Sodium Methoxide, and it also used the facilities of Nitya Laboratories on a job work basis.
The IPO was Rs 80.22 crore and was entirely a fresh issue at Rs 210, the top of the Rs 200 to Rs 210 band. Most of the money was for a new plant for drug intermediates and APIs, a contract research pilot plant and working capital.
Interested in this IPO? Check the live subscription status or browse all upcoming mainboard IPOs.
The bankers & the filings
Who is running the book, and the documents this page is built from.
Lead Manager Track Record
How the book-running lead managers on this issue have priced their past IPOs, measured on listing day.
Almondz Global Securities Ltd
23 issues handledBest listing: Amar Remedies (+100.0%). Weakest: First Winner Industries (-12.0%).
Listing gain compares the listing-day opening price with the issue price, using the IPOs on IPO Guru that this lead manager has taken to market. A strong record reflects how the banker has priced past issues — it is not a forecast for this one. See every issue they have handled on the lead managers page.
Company contact
Frequently asked
What is the GMP of Anu's Laboratories?
The current Grey Market Premium is ₹0.
What is the Anu's Laboratories IPO price band?
₹200 to ₹210, on a face value of ₹10.
When is the allotment?
The basis of allotment is 26 May 2008, with listing on 4 June 2008.
How do I check allotment status?
On the IPO Guru allotment page or on the registrar's site — KFin Technologies Limited.
Every number here traces back to a filing.
IPO Guru tracks GMP, subscription and allotment for every Mainboard and SME issue. Every number on this page is sourced from the RHP, BSE & NSE.
Not investment advice. Grey market premium is an unofficial, unregulated indicator and is not a forecast.
